| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positive-Pressure Respiration | 48 | 2023 | 633 | 9.980 |
Why?
|
| Respiration, Artificial | 53 | 2024 | 2569 | 5.150 |
Why?
|
| Tidal Volume | 26 | 2023 | 490 | 4.630 |
Why?
|
| Esophagus | 18 | 2021 | 1019 | 3.210 |
Why?
|
| Lung Injury | 7 | 2023 | 436 | 3.180 |
Why?
|
| Respiratory Mechanics | 12 | 2023 | 686 | 3.140 |
Why?
|
| Intensive Care Units | 52 | 2024 | 3679 | 2.730 |
Why?
|
| Ventilator-Induced Lung Injury | 12 | 2022 | 122 | 2.700 |
Why?
|
| Acute Lung Injury | 15 | 2021 | 380 | 2.540 |
Why?
|
| Critical Care | 32 | 2024 | 2647 | 2.480 |
Why?
|
| Anesthetics, Inhalation | 5 | 2022 | 570 | 2.040 |
Why?
|
| Respiratory Insufficiency | 14 | 2023 | 1199 | 1.880 |
Why?
|
| Manometry | 8 | 2021 | 445 | 1.840 |
Why?
|
| Sepsis | 21 | 2024 | 2593 | 1.830 |
Why?
|
| Lung | 22 | 2024 | 9856 | 1.700 |
Why?
|
| Hospital Mortality | 32 | 2022 | 5317 | 1.500 |
Why?
|
| Pressure | 12 | 2019 | 1203 | 1.480 |
Why?
|
| Lung Compliance | 6 | 2021 | 195 | 1.350 |
Why?
|
| Perioperative Care | 4 | 2018 | 1002 | 1.270 |
Why?
|
| Shock, Septic | 8 | 2024 | 775 | 1.250 |
Why?
|
| Critical Illness | 20 | 2023 | 2670 | 1.250 |
Why?
|
| Prone Position | 6 | 2018 | 194 | 1.240 |
Why?
|
| Postoperative Complications | 15 | 2022 | 15295 | 1.110 |
Why?
|
| Surgical Procedures, Operative | 5 | 2018 | 1876 | 1.090 |
Why?
|
| Neuromuscular Blocking Agents | 4 | 2021 | 130 | 1.090 |
Why?
|
| Cardiac Surgical Procedures | 10 | 2022 | 3537 | 1.080 |
Why?
|
| Thoracic Wall | 3 | 2018 | 203 | 0.950 |
Why?
|
| Propofol | 5 | 2023 | 629 | 0.890 |
Why?
|
| Methyl Ethers | 2 | 2022 | 205 | 0.860 |
Why?
|
| Neuromuscular Blockade | 4 | 2019 | 146 | 0.800 |
Why?
|
| Respiration | 3 | 2024 | 1653 | 0.780 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2023 | 342 | 0.770 |
Why?
|
| Head Injuries, Closed | 8 | 2000 | 136 | 0.770 |
Why?
|
| Cholecalciferol | 3 | 2021 | 537 | 0.760 |
Why?
|
| Oxygen Inhalation Therapy | 6 | 2022 | 367 | 0.750 |
Why?
|
| Humans | 229 | 2024 | 744343 | 0.740 |
Why?
|
| Vasoconstrictor Agents | 7 | 2023 | 642 | 0.730 |
Why?
|
| Thorax | 1 | 2022 | 547 | 0.690 |
Why?
|
| Fluid Therapy | 6 | 2023 | 593 | 0.670 |
Why?
|
| Mass Casualty Incidents | 5 | 2008 | 183 | 0.650 |
Why?
|
| Preoperative Care | 3 | 2018 | 2250 | 0.650 |
Why?
|
| Respiratory Function Tests | 6 | 2016 | 1616 | 0.640 |
Why?
|
| High-Frequency Ventilation | 2 | 2015 | 87 | 0.630 |
Why?
|
| Anesthesia, Intravenous | 1 | 2018 | 130 | 0.630 |
Why?
|
| Echocardiography | 8 | 2017 | 5102 | 0.610 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2018 | 264 | 0.610 |
Why?
|
| Natriuretic Peptides | 1 | 2018 | 150 | 0.600 |
Why?
|
| Esophageal pH Monitoring | 1 | 2018 | 191 | 0.600 |
Why?
|
| Triage | 8 | 2009 | 976 | 0.580 |
Why?
|
| Patient Admission | 6 | 2017 | 1380 | 0.570 |
Why?
|
| Thoracic Surgery | 1 | 2023 | 719 | 0.560 |
Why?
|
| Ventilators, Mechanical | 6 | 2024 | 292 | 0.560 |
Why?
|
| Vitamin D Deficiency | 3 | 2021 | 1343 | 0.550 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 2 | 2018 | 339 | 0.550 |
Why?
|
| Acute Kidney Injury | 4 | 2013 | 1972 | 0.550 |
Why?
|
| Brain Injuries | 4 | 2017 | 2025 | 0.540 |
Why?
|
| Anesthesiology | 4 | 2018 | 1060 | 0.540 |
Why?
|
| Length of Stay | 14 | 2021 | 6309 | 0.540 |
Why?
|
| Male | 119 | 2021 | 350118 | 0.530 |
Why?
|
| Hemodynamics | 3 | 2017 | 4199 | 0.520 |
Why?
|
| Accidents, Traffic | 5 | 2009 | 819 | 0.510 |
Why?
|
| Monitoring, Physiologic | 5 | 2018 | 1738 | 0.510 |
Why?
|
| Aged | 84 | 2021 | 163280 | 0.510 |
Why?
|
| Middle Aged | 91 | 2021 | 213383 | 0.510 |
Why?
|
| Troponin | 1 | 2018 | 524 | 0.500 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2014 | 40 | 0.500 |
Why?
|
| Intracranial Pressure | 1 | 2017 | 326 | 0.500 |
Why?
|
| Female | 116 | 2021 | 380194 | 0.490 |
Why?
|
| Angiopoietin-2 | 2 | 2013 | 173 | 0.490 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2021 | 1261 | 0.470 |
Why?
|
| Posture | 1 | 2018 | 958 | 0.470 |
Why?
|
| Severity of Illness Index | 16 | 2021 | 15540 | 0.460 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 662 | 0.450 |
Why?
|
| Oliguria | 1 | 2012 | 21 | 0.450 |
Why?
|
| Hypotension | 3 | 2023 | 884 | 0.450 |
Why?
|
| Randomized Controlled Trials as Topic | 14 | 2021 | 9959 | 0.450 |
Why?
|
| Oxygen | 9 | 2021 | 4189 | 0.440 |
Why?
|
| Risk Assessment | 13 | 2018 | 23338 | 0.440 |
Why?
|
| Hypnotics and Sedatives | 5 | 2023 | 1162 | 0.440 |
Why?
|
| Patient Preference | 2 | 2019 | 890 | 0.430 |
Why?
|
| Health Care Costs | 3 | 2018 | 3209 | 0.420 |
Why?
|
| Coronary Artery Bypass | 4 | 2017 | 2289 | 0.420 |
Why?
|
| APACHE | 5 | 2021 | 277 | 0.420 |
Why?
|
| Vitamins | 2 | 2021 | 1622 | 0.410 |
Why?
|
| Organizational Culture | 4 | 2019 | 510 | 0.410 |
Why?
|
| Adult | 71 | 2023 | 214055 | 0.400 |
Why?
|
| Wounds and Injuries | 4 | 2013 | 2400 | 0.400 |
Why?
|
| Protein C | 2 | 2009 | 138 | 0.400 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 1198 | 0.390 |
Why?
|
| Laryngoscopy | 1 | 2017 | 711 | 0.390 |
Why?
|
| Health Status Indicators | 4 | 2020 | 969 | 0.390 |
Why?
|
| Postoperative Care | 1 | 2017 | 1486 | 0.380 |
Why?
|
| Retrospective Studies | 43 | 2023 | 77449 | 0.380 |
Why?
|
| Intubation, Intratracheal | 4 | 2022 | 1364 | 0.370 |
Why?
|
| Renal Replacement Therapy | 1 | 2012 | 257 | 0.370 |
Why?
|
| Erythrocyte Transfusion | 2 | 2013 | 565 | 0.370 |
Why?
|
| Monitoring, Intraoperative | 2 | 2017 | 957 | 0.370 |
Why?
|
| Emergency Service, Hospital | 14 | 2020 | 7659 | 0.370 |
Why?
|
| Pneumonia | 1 | 2022 | 2133 | 0.360 |
Why?
|
| Lactic Acid | 3 | 2013 | 1133 | 0.360 |
Why?
|
| Creatinine | 2 | 2012 | 1919 | 0.360 |
Why?
|
| Interleukin-8 | 1 | 2013 | 690 | 0.360 |
Why?
|
| Phenylephrine | 3 | 1999 | 301 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 8 | 2018 | 7279 | 0.350 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2018 | 1683 | 0.350 |
Why?
|
| Anti-Ulcer Agents | 1 | 2010 | 119 | 0.340 |
Why?
|
| Conscious Sedation | 3 | 2022 | 528 | 0.340 |
Why?
|
| Family | 3 | 2018 | 3147 | 0.340 |
Why?
|
| Anesthetics, Intravenous | 3 | 2022 | 417 | 0.340 |
Why?
|
| von Willebrand Factor | 1 | 2013 | 669 | 0.340 |
Why?
|
| Professional-Family Relations | 3 | 2019 | 482 | 0.340 |
Why?
|
| Histamine H2 Antagonists | 1 | 2010 | 165 | 0.330 |
Why?
|
| Terminology as Topic | 1 | 2016 | 1547 | 0.330 |
Why?
|
| Atracurium | 2 | 2019 | 52 | 0.320 |
Why?
|
| Communication | 3 | 2018 | 3749 | 0.320 |
Why?
|
| Multiple Organ Failure | 2 | 2011 | 390 | 0.320 |
Why?
|
| Influenza, Human | 3 | 2015 | 1479 | 0.320 |
Why?
|
| Stroke Volume | 5 | 2018 | 5007 | 0.310 |
Why?
|
| Prospective Studies | 29 | 2023 | 53288 | 0.310 |
Why?
|
| Stress, Physiological | 3 | 2016 | 1403 | 0.310 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2011 | 612 | 0.310 |
Why?
|
| Cerebrovascular Circulation | 2 | 2021 | 2731 | 0.310 |
Why?
|
| Safety Management | 2 | 2018 | 783 | 0.310 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 481 | 0.310 |
Why?
|
| Trauma Centers | 1 | 2013 | 890 | 0.310 |
Why?
|
| Insulin Infusion Systems | 1 | 2009 | 212 | 0.300 |
Why?
|
| Chemical Warfare | 1 | 2007 | 18 | 0.300 |
Why?
|
| Central Venous Pressure | 1 | 2007 | 78 | 0.300 |
Why?
|
| Chemical Terrorism | 1 | 2007 | 12 | 0.300 |
Why?
|
| Chemical Warfare Agents | 1 | 2007 | 21 | 0.290 |
Why?
|
| Pre-Eclampsia | 2 | 2016 | 1200 | 0.290 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1869 | 0.290 |
Why?
|
| Ventilator Weaning | 3 | 2023 | 148 | 0.290 |
Why?
|
| Hospitalization | 6 | 2015 | 10262 | 0.290 |
Why?
|
| Nitric Oxide | 1 | 2015 | 2132 | 0.290 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 1423 | 0.290 |
Why?
|
| Clinical Protocols | 4 | 2017 | 1462 | 0.280 |
Why?
|
| Cost-Benefit Analysis | 5 | 2018 | 5391 | 0.280 |
Why?
|
| Hyperoxia | 2 | 2019 | 262 | 0.280 |
Why?
|
| Cross Infection | 2 | 2019 | 1416 | 0.280 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2007 | 113 | 0.280 |
Why?
|
| Durable Medical Equipment | 1 | 2006 | 22 | 0.270 |
Why?
|
| Brain Edema | 7 | 2000 | 617 | 0.270 |
Why?
|
| Cerebral Hemorrhage | 3 | 2017 | 2647 | 0.270 |
Why?
|
| Postoperative Period | 5 | 2021 | 1842 | 0.270 |
Why?
|
| Blood Glucose | 4 | 2017 | 6256 | 0.270 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2017 | 1354 | 0.270 |
Why?
|
| Pandemics | 5 | 2021 | 8388 | 0.270 |
Why?
|
| Cause of Death | 4 | 2017 | 3584 | 0.260 |
Why?
|
| Pulmonary Gas Exchange | 3 | 2019 | 382 | 0.260 |
Why?
|
| Prognosis | 17 | 2021 | 29063 | 0.260 |
Why?
|
| Abscess | 1 | 2009 | 607 | 0.260 |
Why?
|
| Risk Factors | 29 | 2021 | 72290 | 0.260 |
Why?
|
| Proton Pump Inhibitors | 1 | 2010 | 526 | 0.260 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2019 | 1066 | 0.250 |
Why?
|
| Hospitals | 3 | 2021 | 3952 | 0.250 |
Why?
|
| Aged, 80 and over | 25 | 2021 | 57776 | 0.250 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 1912 | 0.250 |
Why?
|
| Health Resources | 3 | 2017 | 911 | 0.240 |
Why?
|
| Insulin | 2 | 2009 | 6580 | 0.240 |
Why?
|
| Multivariate Analysis | 10 | 2017 | 12245 | 0.240 |
Why?
|
| Treatment Outcome | 26 | 2023 | 63114 | 0.240 |
Why?
|
| Delirium | 3 | 2021 | 1609 | 0.230 |
Why?
|
| Vascular Surgical Procedures | 2 | 2011 | 1475 | 0.230 |
Why?
|
| Judgment | 1 | 2006 | 281 | 0.230 |
Why?
|
| Craniocerebral Trauma | 2 | 2006 | 482 | 0.230 |
Why?
|
| Clostridium Infections | 1 | 2010 | 548 | 0.230 |
Why?
|
| Boston | 10 | 2021 | 9313 | 0.220 |
Why?
|
| Phenotype | 1 | 2021 | 16365 | 0.220 |
Why?
|
| Aspirin | 4 | 2023 | 3282 | 0.220 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2007 | 290 | 0.220 |
Why?
|
| Time Factors | 21 | 2023 | 40075 | 0.220 |
Why?
|
| Airway Obstruction | 1 | 2008 | 664 | 0.220 |
Why?
|
| Intracranial Embolism | 1 | 2004 | 202 | 0.210 |
Why?
|
| Attitude of Health Personnel | 5 | 2019 | 3843 | 0.210 |
Why?
|
| Hypoglycemia | 1 | 2009 | 861 | 0.200 |
Why?
|
| Survivors | 3 | 2021 | 2291 | 0.200 |
Why?
|
| Image Enhancement | 1 | 2012 | 2921 | 0.200 |
Why?
|
| Patient Positioning | 2 | 2014 | 324 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 2073 | 0.200 |
Why?
|
| Survival | 1 | 2021 | 163 | 0.200 |
Why?
|
| Multiple Trauma | 1 | 2004 | 367 | 0.200 |
Why?
|
| Anesthesia, General | 4 | 2022 | 1171 | 0.190 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 1073 | 0.190 |
Why?
|
| Heart Ventricles | 2 | 2012 | 3821 | 0.190 |
Why?
|
| Pneumonia, Ventilator-Associated | 2 | 2014 | 274 | 0.190 |
Why?
|
| Disease Outbreaks | 2 | 2007 | 1772 | 0.190 |
Why?
|
| Predictive Value of Tests | 11 | 2016 | 15076 | 0.180 |
Why?
|
| Blood Gas Analysis | 2 | 2019 | 383 | 0.180 |
Why?
|
| Supine Position | 2 | 2018 | 205 | 0.180 |
Why?
|
| Health Care Rationing | 2 | 2008 | 437 | 0.180 |
Why?
|
| Water-Electrolyte Balance | 1 | 2021 | 346 | 0.180 |
Why?
|
| Respiration Disorders | 1 | 2023 | 371 | 0.180 |
Why?
|
| Deep Sedation | 1 | 2021 | 121 | 0.180 |
Why?
|
| Catheterization | 2 | 2016 | 1470 | 0.170 |
Why?
|
| Treatment Failure | 3 | 2020 | 2618 | 0.170 |
Why?
|
| Troponin T | 1 | 2004 | 754 | 0.170 |
Why?
|
| Hospital Bed Capacity | 2 | 2014 | 214 | 0.170 |
Why?
|
| Rwanda | 5 | 2021 | 703 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2019 | 2282 | 0.170 |
Why?
|
| Survival Rate | 6 | 2020 | 12788 | 0.170 |
Why?
|
| Sodium Chloride | 3 | 2014 | 625 | 0.170 |
Why?
|
| Registries | 2 | 2021 | 8089 | 0.160 |
Why?
|
| Point-of-Care Systems | 4 | 2017 | 1177 | 0.160 |
Why?
|
| ROC Curve | 6 | 2021 | 3527 | 0.160 |
Why?
|
| Double-Blind Method | 8 | 2021 | 12026 | 0.160 |
Why?
|
| Acetaminophen | 2 | 2021 | 545 | 0.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2009 | 1536 | 0.160 |
Why?
|
| Health Personnel | 3 | 2019 | 3218 | 0.160 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 452 | 0.160 |
Why?
|
| Diuretics | 1 | 2021 | 592 | 0.160 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3133 | 0.160 |
Why?
|
| United States | 23 | 2020 | 69872 | 0.160 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 1956 | 0.160 |
Why?
|
| Dissent and Disputes | 1 | 2019 | 141 | 0.160 |
Why?
|
| Emergency Medical Services | 2 | 2008 | 1917 | 0.150 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3240 | 0.150 |
Why?
|
| Anesthesia Recovery Period | 1 | 2018 | 157 | 0.150 |
Why?
|
| Blood Platelet Disorders | 1 | 2018 | 58 | 0.150 |
Why?
|
| Logistic Models | 11 | 2017 | 13408 | 0.150 |
Why?
|
| Survival Analysis | 8 | 2019 | 10252 | 0.150 |
Why?
|
| Exhalation | 1 | 2018 | 167 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2024 | 817 | 0.150 |
Why?
|
| Health Services Misuse | 1 | 2019 | 243 | 0.150 |
Why?
|
| Intraoperative Care | 1 | 2021 | 767 | 0.150 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2029 | 0.140 |
Why?
|
| Intention | 1 | 2019 | 341 | 0.140 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 412 | 0.140 |
Why?
|
| Early Ambulation | 1 | 2016 | 44 | 0.140 |
Why?
|
| Fibrinolytic Agents | 3 | 2021 | 2158 | 0.140 |
Why?
|
| Drug Resistance, Microbial | 1 | 2019 | 862 | 0.140 |
Why?
|
| Inhalation | 1 | 2016 | 143 | 0.140 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 104 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 6538 | 0.130 |
Why?
|
| Odds Ratio | 5 | 2017 | 9849 | 0.130 |
Why?
|
| Shock | 1 | 2018 | 318 | 0.130 |
Why?
|
| Self-Assessment | 1 | 2018 | 390 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 365 | 0.130 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2017 | 346 | 0.130 |
Why?
|
| Respiratory Dead Space | 1 | 2015 | 30 | 0.130 |
Why?
|
| Myxoma | 1 | 1996 | 130 | 0.130 |
Why?
|
| Lung Diseases | 2 | 2016 | 1886 | 0.130 |
Why?
|
| Cohort Studies | 13 | 2021 | 40561 | 0.130 |
Why?
|
| Demography | 3 | 2016 | 1656 | 0.130 |
Why?
|
| Respiratory Rate | 1 | 2016 | 162 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 1285 | 0.130 |
Why?
|
| Resuscitation Orders | 1 | 2017 | 269 | 0.130 |
Why?
|
| Heart Valves | 1 | 2017 | 291 | 0.130 |
Why?
|
| Bradycardia | 1 | 2017 | 307 | 0.130 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 567 | 0.130 |
Why?
|
| Follow-Up Studies | 10 | 2021 | 39050 | 0.130 |
Why?
|
| Expert Testimony | 1 | 2017 | 356 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 432 | 0.120 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2014 | 68 | 0.120 |
Why?
|
| Dexmedetomidine | 1 | 2019 | 315 | 0.120 |
Why?
|
| Infusions, Intravenous | 4 | 2021 | 2274 | 0.120 |
Why?
|
| Blood Transfusion | 2 | 2018 | 1301 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 500 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2017 | 379 | 0.120 |
Why?
|
| Cognition | 3 | 2021 | 6770 | 0.110 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 13989 | 0.110 |
Why?
|
| Lung Volume Measurements | 1 | 2014 | 378 | 0.110 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 458 | 0.110 |
Why?
|
| Intubation | 1 | 2013 | 141 | 0.110 |
Why?
|
| Salvage Therapy | 1 | 2020 | 1275 | 0.110 |
Why?
|
| Glasgow Coma Scale | 2 | 2013 | 570 | 0.110 |
Why?
|
| Comparative Effectiveness Research | 1 | 2018 | 681 | 0.110 |
Why?
|
| Rewarming | 1 | 2013 | 61 | 0.110 |
Why?
|
| Cost Savings | 1 | 2018 | 926 | 0.110 |
Why?
|
| Isoflurane | 1 | 2016 | 380 | 0.110 |
Why?
|
| Blood Pressure | 4 | 2007 | 8554 | 0.110 |
Why?
|
| Humidity | 1 | 2013 | 197 | 0.110 |
Why?
|
| Shock, Cardiogenic | 2 | 2015 | 688 | 0.110 |
Why?
|
| Professional-Patient Relations | 1 | 2018 | 737 | 0.110 |
Why?
|
| Young Adult | 10 | 2021 | 56430 | 0.110 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2214 | 0.110 |
Why?
|
| Heart Neoplasms | 1 | 1996 | 374 | 0.110 |
Why?
|
| Physical Therapy Modalities | 1 | 2016 | 550 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2016 | 19905 | 0.110 |
Why?
|
| Infection Control | 2 | 2018 | 966 | 0.110 |
Why?
|
| Cytokines | 1 | 2007 | 7322 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2017 | 514 | 0.110 |
Why?
|
| Empirical Research | 1 | 2012 | 120 | 0.110 |
Why?
|
| Probability | 4 | 2016 | 2505 | 0.110 |
Why?
|
| Developing Countries | 4 | 2019 | 2815 | 0.110 |
Why?
|
| Hypothermia, Induced | 2 | 2013 | 752 | 0.110 |
Why?
|
| Research | 1 | 2021 | 1999 | 0.110 |
Why?
|
| Executive Function | 1 | 2021 | 1364 | 0.100 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2013 | 1133 | 0.100 |
Why?
|
| Liver Failure | 1 | 2014 | 241 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 638 | 0.100 |
Why?
|
| Cardiac Output | 1 | 2014 | 854 | 0.100 |
Why?
|
| Video Recording | 1 | 2017 | 949 | 0.100 |
Why?
|
| Incidence | 9 | 2019 | 20947 | 0.100 |
Why?
|
| Wound Infection | 1 | 2014 | 242 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7181 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 459 | 0.100 |
Why?
|
| Ascites | 1 | 2013 | 344 | 0.100 |
Why?
|
| Disaster Planning | 2 | 2008 | 549 | 0.100 |
Why?
|
| Academic Medical Centers | 6 | 2018 | 2759 | 0.100 |
Why?
|
| Blood Pressure Determination | 2 | 2013 | 634 | 0.100 |
Why?
|
| Specific Gravity | 3 | 1999 | 20 | 0.100 |
Why?
|
| Consensus | 2 | 2014 | 2959 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 2161 | 0.100 |
Why?
|
| Patient Care Planning | 1 | 2016 | 921 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1401 | 0.100 |
Why?
|
| Hernia, Ventral | 1 | 2013 | 176 | 0.090 |
Why?
|
| Jews | 1 | 2012 | 385 | 0.090 |
Why?
|
| Research Design | 5 | 2020 | 5987 | 0.090 |
Why?
|
| Arabs | 1 | 2012 | 178 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2021 | 1677 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4420 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 1213 | 0.090 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 489 | 0.090 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2009 | 59 | 0.090 |
Why?
|
| Brain Diseases | 1 | 1999 | 1563 | 0.090 |
Why?
|
| Urodynamics | 1 | 2011 | 347 | 0.090 |
Why?
|
| Matched-Pair Analysis | 1 | 2010 | 288 | 0.090 |
Why?
|
| Pleural Cavity | 1 | 2009 | 22 | 0.090 |
Why?
|
| Compliance | 1 | 2009 | 104 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2013 | 980 | 0.090 |
Why?
|
| New England | 2 | 2023 | 1022 | 0.090 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 1164 | 0.090 |
Why?
|
| Area Under Curve | 3 | 2010 | 1654 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 1018 | 0.090 |
Why?
|
| Vitamin D | 2 | 2020 | 3223 | 0.090 |
Why?
|
| Leg | 1 | 2014 | 1116 | 0.080 |
Why?
|
| Chi-Square Distribution | 5 | 2017 | 3508 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1486 | 0.080 |
Why?
|
| Glucose | 2 | 1998 | 4397 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 2557 | 0.080 |
Why?
|
| Reference Values | 1 | 2016 | 4982 | 0.080 |
Why?
|
| Hypertension | 2 | 1999 | 8480 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2373 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2006 | 6365 | 0.080 |
Why?
|
| Adolescent | 8 | 2021 | 85781 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2000 | 8301 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2011 | 3068 | 0.080 |
Why?
|
| Emergency Treatment | 3 | 2007 | 517 | 0.080 |
Why?
|
| Propensity Score | 2 | 2017 | 1781 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 1855 | 0.080 |
Why?
|
| Respiratory Protective Devices | 1 | 2008 | 45 | 0.080 |
Why?
|
| Education, Continuing | 1 | 2008 | 112 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 1439 | 0.080 |
Why?
|
| Schools, Medical | 1 | 2014 | 880 | 0.080 |
Why?
|
| Evidence-Based Medicine | 3 | 2015 | 3610 | 0.080 |
Why?
|
| Thrombosis | 1 | 2021 | 2968 | 0.080 |
Why?
|
| Climate | 1 | 2008 | 147 | 0.080 |
Why?
|
| Hemorrhage | 1 | 1999 | 3461 | 0.080 |
Why?
|
| Hypovolemia | 1 | 2007 | 45 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2012 | 8324 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 6622 | 0.070 |
Why?
|
| Intraoperative Period | 2 | 2016 | 520 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2018 | 2531 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 10943 | 0.070 |
Why?
|
| Lactates | 1 | 2008 | 432 | 0.070 |
Why?
|
| Myocardium | 1 | 2000 | 4776 | 0.070 |
Why?
|
| Animals | 15 | 2018 | 168757 | 0.070 |
Why?
|
| Oximetry | 2 | 2021 | 471 | 0.070 |
Why?
|
| Hypothermia | 1 | 2008 | 189 | 0.070 |
Why?
|
| Maximum Tolerated Dose | 1 | 2009 | 892 | 0.070 |
Why?
|
| Resuscitation | 2 | 2024 | 658 | 0.070 |
Why?
|
| Hospitals, University | 3 | 2019 | 571 | 0.070 |
Why?
|
| Seat Belts | 1 | 2006 | 57 | 0.070 |
Why?
|
| Rats | 9 | 2000 | 24260 | 0.070 |
Why?
|
| Dinoprostone | 2 | 2000 | 600 | 0.070 |
Why?
|
| Swine | 1 | 2016 | 5917 | 0.070 |
Why?
|
| Pulmonary Ventilation | 1 | 2008 | 373 | 0.070 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 14722 | 0.070 |
Why?
|
| Age Factors | 5 | 2018 | 18370 | 0.070 |
Why?
|
| Fever | 1 | 2013 | 1616 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 2170 | 0.070 |
Why?
|
| Accreditation | 1 | 2008 | 450 | 0.070 |
Why?
|
| Europe | 3 | 2019 | 3339 | 0.060 |
Why?
|
| Risk Management | 1 | 2009 | 571 | 0.060 |
Why?
|
| Stomach | 1 | 2009 | 697 | 0.060 |
Why?
|
| Health Planning Guidelines | 1 | 2005 | 163 | 0.060 |
Why?
|
| Bioterrorism | 1 | 2005 | 143 | 0.060 |
Why?
|
| Quality of Life | 2 | 2018 | 12804 | 0.060 |
Why?
|
| Catheterization, Peripheral | 2 | 2013 | 345 | 0.060 |
Why?
|
| Heart Rate | 3 | 2017 | 4091 | 0.060 |
Why?
|
| Hospitals, Urban | 3 | 2015 | 499 | 0.060 |
Why?
|
| Comorbidity | 5 | 2012 | 10388 | 0.060 |
Why?
|
| Massachusetts | 2 | 2016 | 8663 | 0.060 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 414 | 0.060 |
Why?
|
| Reoperation | 1 | 2014 | 4201 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 1863 | 0.060 |
Why?
|
| Israel | 3 | 2012 | 796 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2016 | 21746 | 0.060 |
Why?
|
| Decision Making | 1 | 2018 | 3887 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 1782 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2022 | 2309 | 0.060 |
Why?
|
| Urban Population | 2 | 2014 | 2021 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 1831 | 0.060 |
Why?
|
| Urinary Bladder | 1 | 2009 | 1172 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 15165 | 0.060 |
Why?
|
| Quality of Health Care | 2 | 2017 | 4371 | 0.060 |
Why?
|
| Electrocardiography | 3 | 2018 | 6442 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2013 | 1470 | 0.060 |
Why?
|
| Body Water | 3 | 2000 | 343 | 0.060 |
Why?
|
| Subclavian Vein | 1 | 2002 | 54 | 0.050 |
Why?
|
| Mental Recall | 2 | 2021 | 1205 | 0.050 |
Why?
|
| Thoracic Injuries | 1 | 2005 | 272 | 0.050 |
Why?
|
| Biomedical Research | 2 | 2017 | 3309 | 0.050 |
Why?
|
| Death | 2 | 2024 | 678 | 0.050 |
Why?
|
| Clinical Trials as Topic | 3 | 2021 | 7913 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 3396 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2014 | 2151 | 0.050 |
Why?
|
| Preoperative Period | 2 | 2017 | 549 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2007 | 581 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2007 | 1585 | 0.050 |
Why?
|
| Pulse Therapy, Drug | 1 | 2021 | 35 | 0.050 |
Why?
|
| Vena Cava, Superior | 1 | 2002 | 193 | 0.050 |
Why?
|
| Equipment Design | 1 | 2009 | 3582 | 0.050 |
Why?
|
| Stroke | 1 | 2004 | 9981 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 1813 | 0.050 |
Why?
|
| Artifacts | 1 | 2009 | 1904 | 0.050 |
Why?
|
| Partial Thromboplastin Time | 1 | 2021 | 206 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2004 | 478 | 0.050 |
Why?
|
| Body Temperature | 2 | 2008 | 777 | 0.050 |
Why?
|
| Polypharmacy | 1 | 2023 | 294 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 3923 | 0.050 |
Why?
|
| Respiratory System | 1 | 2023 | 557 | 0.050 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2000 | 148 | 0.040 |
Why?
|
| Peroxidases | 1 | 2000 | 138 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 2015 | 1681 | 0.040 |
Why?
|
| Sex Factors | 2 | 2011 | 10397 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 2018 | 2453 | 0.040 |
Why?
|
| Statistics, Nonparametric | 3 | 2010 | 2886 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 2216 | 0.040 |
Why?
|
| Time | 1 | 2021 | 542 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 329 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2004 | 1011 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 1573 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 480 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 2001 | 338 | 0.040 |
Why?
|
| International Cooperation | 1 | 2005 | 1420 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 489 | 0.040 |
Why?
|
| Neurologic Examination | 2 | 2000 | 930 | 0.040 |
Why?
|
| Enterobacteriaceae | 1 | 2019 | 169 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 188 | 0.040 |
Why?
|
| Random Allocation | 2 | 2000 | 2429 | 0.040 |
Why?
|
| Anesthetics, Dissociative | 1 | 1998 | 80 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 2000 | 981 | 0.040 |
Why?
|
| Partial Pressure | 1 | 2017 | 254 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2000 | 371 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2005 | 1359 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2018 | 5078 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2019 | 270 | 0.040 |
Why?
|
| Algorithms | 2 | 2016 | 13881 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 6489 | 0.040 |
Why?
|
| Chest Wall Oscillation | 1 | 2017 | 12 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2019 | 306 | 0.040 |
Why?
|
| Propylamines | 1 | 1998 | 165 | 0.040 |
Why?
|
| Patient Selection | 1 | 2009 | 4215 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 972 | 0.040 |
Why?
|
| Sputum | 1 | 2019 | 476 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 648 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 683 | 0.040 |
Why?
|
| Potassium | 2 | 1998 | 1336 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 697 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 12959 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2016 | 5102 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 6993 | 0.040 |
Why?
|
| Forecasting | 1 | 2006 | 2951 | 0.040 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2000 | 476 | 0.040 |
Why?
|
| Heart Failure | 2 | 2013 | 10900 | 0.040 |
Why?
|
| Mortality | 2 | 2019 | 2864 | 0.040 |
Why?
|
| Markov Chains | 1 | 2020 | 969 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2017 | 25625 | 0.040 |
Why?
|
| Serum Albumin | 1 | 1999 | 676 | 0.030 |
Why?
|
| Austria | 1 | 2016 | 203 | 0.030 |
Why?
|
| Fluorobenzenes | 1 | 1998 | 183 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 25043 | 0.030 |
Why?
|
| Sodium | 2 | 1998 | 1623 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2018 | 6459 | 0.030 |
Why?
|
| Linear Models | 1 | 2006 | 5952 | 0.030 |
Why?
|
| Patient Discharge | 2 | 2021 | 3313 | 0.030 |
Why?
|
| Fentanyl | 2 | 2014 | 410 | 0.030 |
Why?
|
| Disease Progression | 4 | 2011 | 13284 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2006 | 2266 | 0.030 |
Why?
|
| Social Perception | 1 | 2019 | 425 | 0.030 |
Why?
|
| Radiography, Thoracic | 2 | 2017 | 1265 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 426 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2000 | 1726 | 0.030 |
Why?
|
| Computer Communication Networks | 1 | 1996 | 295 | 0.030 |
Why?
|
| Pregnancy | 2 | 2016 | 29144 | 0.030 |
Why?
|
| Diaphragm | 1 | 2016 | 349 | 0.030 |
Why?
|
| Hospitals, Public | 1 | 2016 | 207 | 0.030 |
Why?
|
| Anesthesia | 1 | 2006 | 1561 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2014 | 11727 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 862 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2019 | 792 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 1105 | 0.030 |
Why?
|
| Lifting | 1 | 2014 | 56 | 0.030 |
Why?
|
| Quality Improvement | 2 | 2019 | 3749 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6487 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2000 | 3701 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3255 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2009 | 4599 | 0.030 |
Why?
|
| Early Diagnosis | 2 | 2010 | 1184 | 0.030 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 1996 | 272 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2014 | 170 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 603 | 0.030 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2015 | 219 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 1996 | 329 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 1372 | 0.030 |
Why?
|
| Models, Biological | 1 | 2009 | 9583 | 0.030 |
Why?
|
| Risk | 2 | 2016 | 9687 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1999 | 794 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2004 | 2002 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1998 | 895 | 0.030 |
Why?
|
| Quality Control | 1 | 2015 | 841 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1590 | 0.030 |
Why?
|
| Causality | 2 | 2011 | 1275 | 0.030 |
Why?
|
| Pleura | 1 | 2014 | 235 | 0.030 |
Why?
|
| Oscillometry | 1 | 2013 | 147 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2017 | 592 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12354 | 0.030 |
Why?
|
| Midazolam | 1 | 2014 | 270 | 0.030 |
Why?
|
| Ketamine | 1 | 1998 | 500 | 0.030 |
Why?
|
| Mice | 2 | 2016 | 81183 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 584 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 1996 | 935 | 0.030 |
Why?
|
| Focus Groups | 1 | 2016 | 1321 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 1998 | 1017 | 0.030 |
Why?
|
| Obesity | 1 | 2014 | 12745 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 20129 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1998 | 941 | 0.020 |
Why?
|
| Faculty | 1 | 2014 | 386 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2017 | 1609 | 0.020 |
Why?
|
| Catheters | 1 | 2014 | 425 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2017 | 7729 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 18029 | 0.020 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 3674 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2000 | 1938 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4933 | 0.020 |
Why?
|
| Minnesota | 1 | 2010 | 344 | 0.020 |
Why?
|
| Policy Making | 1 | 2014 | 554 | 0.020 |
Why?
|
| Morphine | 1 | 2014 | 657 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2019 | 2052 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 2148 | 0.020 |
Why?
|
| Radiography | 2 | 2016 | 7023 | 0.020 |
Why?
|
| Brain | 4 | 1999 | 26385 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2376 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3870 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 2 | 2000 | 425 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2014 | 2971 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1998 | 3200 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2008 | 114 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 2682 | 0.020 |
Why?
|
| Calcium | 2 | 1998 | 5756 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
| Receptor, TIE-2 | 1 | 2008 | 178 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2077 | 0.020 |
Why?
|
| Physicians | 1 | 2006 | 4567 | 0.020 |
Why?
|
| Kinetics | 1 | 2015 | 6473 | 0.020 |
Why?
|
| Gestational Age | 1 | 2016 | 3493 | 0.020 |
Why?
|
| Patient Participation | 1 | 2016 | 1457 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8642 | 0.020 |
Why?
|
| Brain Ischemia | 2 | 1998 | 3265 | 0.020 |
Why?
|
| Emergencies | 1 | 2013 | 1170 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2014 | 2740 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3528 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2007 | 199 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6386 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2014 | 12720 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 2795 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2018 | 3589 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 3670 | 0.020 |
Why?
|
| Urea | 1 | 2007 | 450 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2015 | 2948 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3229 | 0.020 |
Why?
|
| Automobiles | 1 | 2005 | 116 | 0.020 |
Why?
|
| Infant | 2 | 2017 | 35136 | 0.020 |
Why?
|
| Necrosis | 2 | 1999 | 1643 | 0.020 |
Why?
|
| Poverty | 1 | 2016 | 2660 | 0.020 |
Why?
|
| Child | 1 | 2012 | 77709 | 0.020 |
Why?
|
| Immunoassay | 1 | 2007 | 752 | 0.010 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2008 | 454 | 0.010 |
Why?
|
| Hypothalamus | 2 | 2000 | 1063 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 2007 | 591 | 0.010 |
Why?
|
| Internationality | 1 | 2008 | 1003 | 0.010 |
Why?
|
| Perfusion | 1 | 2007 | 1360 | 0.010 |
Why?
|
| Neutrophils | 1 | 2015 | 3719 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2459 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15226 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2016 | 5985 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4669 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7149 | 0.010 |
Why?
|
| Benchmarking | 1 | 2008 | 1042 | 0.010 |
Why?
|
| Health Policy | 1 | 2014 | 2661 | 0.010 |
Why?
|
| Paracentesis | 1 | 2001 | 95 | 0.010 |
Why?
|
| Halothane | 1 | 2000 | 206 | 0.010 |
Why?
|
| Health Status | 1 | 2013 | 4034 | 0.010 |
Why?
|
| Hemodilution | 1 | 1999 | 114 | 0.010 |
Why?
|
| Morbidity | 1 | 2005 | 1769 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2005 | 1240 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 2007 | 1207 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2000 | 320 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 7785 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2012 | 9146 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2000 | 611 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 8436 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1996 | 5788 | 0.010 |
Why?
|
| Inflammation | 1 | 2015 | 10638 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 1998 | 1014 | 0.010 |
Why?
|
| Magnesium | 1 | 1998 | 813 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 41006 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 5751 | 0.010 |
Why?
|
| Homeostasis | 1 | 1998 | 3340 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 8949 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 2001 | 4838 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 5708 | 0.000 |
Why?
|
| Apoptosis | 1 | 1998 | 9727 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1998 | 23403 | 0.000 |
Why?
|